enisamium iodide
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
2
Phase 4
0
Earliest trial started Apr 13, 2009 (NCT04682444)
Timeline
Indications
Mechanism of action
- Influenza A virusINHIBITOR
Influenza A virus inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
C[n+]1ccc(C(=O)NCc2ccccc2)cc1.[I-]- Mol. weight
- 354.19 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1716983 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04682873 | Phase 3 | May 15, 2020 | Bogomolets National Medical University, Farmak |
| NCT04682444 | Phase 2/Phase 3 (Phase 3) | Apr 13, 2009 | Farmak, Research Institute of Influenza, Russia |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Farmak | For profit | 2 | 2 | 1 | 2009 |
| Bogomolets National Medical University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Research Institute of Influenza, Russia | Academic/Hospital | 1 | 0 | 1 | 2009 |
3 organizations
Page 1 / 1